37
Participants
Start Date
February 16, 2021
Primary Completion Date
August 25, 2021
Study Completion Date
November 21, 2022
Shockwave Medical M5+ Peripheral Intravascular Lithotripsy (IVL)
The Shockwave Medical M5+ Peripheral IVL System is indicated for lithotripsy-enhanced, low-pressure balloon dilatation of lesions, including calcified lesions, in the peripheral vasculature, including the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries. This device is not intended for use in coronary, carotid, or cerebrovascular arteries.
Auckland City Hospital, Auckland
Prince of Wales Hospital, Randwick
Waikato District Hospital, Hamilton
Perth Institute of Vascular Research, Nedlands
Christchurch Hospital, Christchurch
NC Heart and Vascular Research, Raleigh
Midwest Cardiovascular Research Foundation, Davenport
St. John Clinic, Bartlesville
Shockwave Medical, Inc.
INDUSTRY